Renal Denervation

This channel includes news and new technology innovations for renal denervation used to treat hypertension. Renal denervation is a catheter-based therapy. The catheter is into the renal artery and delivers radio-frequency energy to ablate the nerves in the vessel wall that regulate vasoconstriction. This leaves the vessel permanently in the widest open position to allow greater blood flow to the kidneys. This enables greater filtration of the blood and removal of excess water that causes hypertension

Blog | March 25, 2014
By Dave Fornell, DAIC editor Data from several cutting-edge device clinical trials will be presented as late-breakers...
American College of Cardiology Clinical Trial Cath Lab EP Cardiac Diagnostics
News | February 07, 2014
February 7, 2014 — Results from several late-breaking clinical trials will be presented during  the American College of...
ReCor Medical Paradise System Renal Denervation RDN Therapy Hypertension
News | January 28, 2014
January 28, 2014 — ReCor Medical advanced its Paradise System for renal denervation (RDN) for treatment resistant...
Medtronic, symplicity, renal denervation
Feature | January 09, 2014
January 9, 2014 — Medtronic Inc. announced its U.S. pivotal trial for its Symplicity renal denervation system to treat...
medtronic symplicity renal denervation therapy hypertension cath lab trial study
News | January 02, 2014
January 2, 2014 — Medtronic Inc. announced that the first patients were randomized in Symplicity HTN-4, which will...
acc pharmaceuticals renal denervation heart valve repair antiplatelet therapy
Feature | December 24, 2013
December 24, 2013 — Clinical trials for a promising new class of cholesterol-lowering medications, a long-awaited...
medtronic symplicity spyral renal denervation cath lab hypertension treatment G3
Feature | December 06, 2013
December 6, 2013 — Medtronic Inc. announced CE mark in Europe and Therapeutic Goods Administration (TGA) listing in...
News | December 06, 2013
December 6, 2013 – Medtronic, Inc. presented three-year data from SYMPLICITY HTN-2, the first and longest-running...
News | November 13, 2013
November 13, 2013 — Petr Neuzil, M.D., Nemocnice Na Homolce Hospital, Prague, Czech Republic, presented three-month...
renal denervation clinical trial study hypertension cath medtronic symplicity
Feature | November 13, 2013
November 13, 2013 — Medtronic Inc. announced that the U.S. Food and Drug Administration (FDA) has approved an...
renal denervation clinical trial study hypertension vessix boston scientific
News | October 31, 2013
October 31, 2013 — Patients treated with the Boston Scientific Vessix Renal Denervation System experienced a...
News | October 28, 2013
October 28, 2013 — CBSET, a not-for-profit preclinical research institute dedicated to biomedical research, education...
renal denervation therapy hypertension kona medical morningside
News | October 25, 2013
October 25, 2013 — Kona Medical Inc. announced it has closed a Series D equity financing of $10 million. Morningside...
renal denervation, Symplicity

An illustration of how renal denervation therapy is delivered, in this case using a Medtronic Symplicity device.

Feature | October 14, 2013
October 14, 2013 — Since its debut in 2010, the renal denervation market has generated enthusiasm across the medical...
Feature | September 03, 2013
September 3, 2013 — St. Jude Medical Inc. announced the CE mark approval of its next-generation EnligHTN renal...